{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:49:32Z","timestamp":1781545772118,"version":"3.54.5"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,6,17]],"date-time":"2009-06-17T00:00:00Z","timestamp":1245196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s10822-009-9284-1","type":"journal-article","created":{"date-parts":[[2009,6,16]],"date-time":"2009-06-16T16:20:00Z","timestamp":1245169200000},"page":"459-473","source":"Crossref","is-referenced-by-count":51,"title":["The multiple roles of computational chemistry in fragment-based drug design"],"prefix":"10.1007","volume":"23","author":[{"given":"Richard","family":"Law","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hesterkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Godemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Fryatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Courtney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,17]]},"reference":[{"issue":"4","key":"9284_CR1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1538-7836.2007.02436.x","volume":"5","author":"G Agnelli","year":"2007","unstructured":"Agnelli G, Haas S, Ginsberg JS, Krueger KA, Dmitrienko A, Brandt JT (2007) A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement. J Thromb Haemost 5(4):746\u2013753. doi: 10.1111\/j.1538-7836.2007.02436.x","journal-title":"J Thromb Haemost"},{"issue":"6","key":"9284_CR2","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2174\/156802607782341127","volume":"7","author":"JS Albert","year":"2007","unstructured":"Albert JS (2007) Editorial: fragment-based drug discovery. Curr Top Med Chem 7(6):1543. doi: 10.2174\/156802607782341127","journal-title":"Curr Top Med Chem"},{"issue":"16","key":"9284_CR3","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.2174\/156802607782341091","volume":"7","author":"JS Albert","year":"2007","unstructured":"Albert JS, Blomberg N, Breeze AL, Brown AJ, Burrows JN, Edwards PD, Folmer RH, Geschwindner S, Griffen EJ, Kenny PW et al (2007) An integrated approach to fragment-based lead generation: philosophy, strategy and case studies from AstraZeneca\u2019s drug discovery programmes. Curr Top Med Chem 7(16):1600\u20131629. doi: 10.2174\/156802607782341091","journal-title":"Curr Top Med Chem"},{"issue":"16","key":"9284_CR4","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2174\/156802607782341082","volume":"7","author":"AA Alex","year":"2007","unstructured":"Alex AA, Flocco MM (2007) Fragment-based drug discovery: what has it achieved so far? Curr Top Med Chem 7(16):1544\u20131567. doi: 10.2174\/156802607782341082","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"9284_CR5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1073\/pnas.0811325106","volume":"106","author":"DR Artis","year":"2009","unstructured":"Artis DR, Lin JJ, Zhang C, Wang W, Mehra U, Perreault M, Erbe D, Krupka HI, England BP, Arnold J et al (2009) Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent. Proc Natl Acad Sci USA 106(1):262\u2013267. doi: 10.1073\/pnas.0811325106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"9284_CR6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nchembio831","volume":"2","author":"K Babaoglu","year":"2006","unstructured":"Babaoglu K, Shoichet BK (2006) Deconstructing fragment-based inhibitor discovery. Nat Chem Biol 2(12):720\u2013723. doi: 10.1038\/nchembio831","journal-title":"Nat Chem Biol"},{"issue":"3","key":"9284_CR7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1517\/17460441.1.3.225","volume":"1","author":"J Barker","year":"2006","unstructured":"Barker J, Courtney S, Hesterkamp T, Ullmann D, Whittaker M (2006) Fragment screening by biochemical assay. Expert Opin Drug Discov 1(3):225\u2013236. doi: 10.1517\/17460441.1.3.225","journal-title":"Expert Opin Drug Discov"},{"issue":"6","key":"9284_CR8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/cmdc.200900011","volume":"4","author":"JJ Barker","year":"2009","unstructured":"Barker JJ, Barker O, Boggio R, Chauhan V, Cheng RKY, Corden V, Courtney SM, Edwards N, Falque VM, Fusar F, Gardiner M, Hamelin EMN, Hesterkamp T, Ichihara O, Jones RS, Mather O, Mercurio C, Minucci S, Montalbetti CAGN, M\u00fcller A, Patel D, Phillips BG, Varasi M, Whittaker M, Winkler D, Yarnold CJ (2009) Fragment-based Identification of Hsp90 Inhibitors. Chem Med Chem 4(6):963\u2013966","journal-title":"Chem Med Chem"},{"issue":"4","key":"9284_CR9","first-page":"422","volume":"10","author":"S Bartoli","year":"2007","unstructured":"Bartoli S, Fincham CI, Fattori D (2007) Fragment-based drug design: combining philosophy with technology. Curr Opin Drug Discov Devel 10(4):422\u2013429","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"6","key":"9284_CR10","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1021\/ci049806z","volume":"44","author":"N Baurin","year":"2004","unstructured":"Baurin N, Aboul-Ela F, Barril X, Davis B, Drysdale M, Dymock B, Finch H, Fromont C, Richardson C, Simmonite H et al (2004) Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets. J Chem Inf Comput Sci 44(6):2157\u20132166. doi: 10.1021\/ci049806z","journal-title":"J Chem Inf Comput Sci"},{"key":"9284_CR11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/3527608761.ch11","volume-title":"Fragment based lead discovery optimization using X-ray crystallography, computational chemistry, and high throughput organic synthesis. Fragment-based approaches in drug discovery","author":"J Blaney","year":"2006","unstructured":"Blaney J, Nienaber V, Burley SK (2006) Fragment based lead discovery optimization using X-ray crystallography, computational chemistry, and high throughput organic synthesis. Fragment-based approaches in drug discovery, vol 34. Wiley, Weinheim, pp 215\u2013248"},{"issue":"14","key":"9284_CR12","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1021\/jm000017s","volume":"43","author":"HJ Boehm","year":"2000","unstructured":"Boehm HJ, Boehringer M, Bur D, Gmuender H, Huber W, Klaus W, Kostrewa D, Kuehne H, Luebbers T, Meunier-Keller N et al (2000) Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. J Med Chem 43(14):2664\u20132674. doi: 10.1021\/jm000017s","journal-title":"J Med Chem"},{"issue":"1","key":"9284_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00124387","volume":"6","author":"HJ Bohm","year":"1992","unstructured":"Bohm HJ (1992) The computer program LUDI: a new method for the de novo design of enzyme inhibitors. J Comput Aided Mol Des 6(1):61\u201378. doi: 10.1007\/BF00124387","journal-title":"J Comput Aided Mol Des"},{"key":"9284_CR14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/9780470721551.ch3","volume-title":"Assembling a fragment library. Fragment-based drug discovery; a practical approach","author":"M Brewer","year":"2008","unstructured":"Brewer M, Ichihara O, Kirchoff C, Schade M, Whittaker M (2008) Assembling a fragment library. Fragment-based drug discovery; a practical approach. Wiley, Weinheim, pp 39\u201362"},{"issue":"2","key":"9284_CR15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/jm701018h","volume":"51","author":"PA Brough","year":"2008","unstructured":"Brough PA, Aherne W, Barril X, Borgognoni J, Boxall K, Cansfield JE, Cheung KM, Collins I, Davies NG, Drysdale MJ et al (2008) 4, 5-Diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer. J Med Chem 51(2):196\u2013218. doi: 10.1021\/jm701018h","journal-title":"J Med Chem"},{"issue":"4","key":"9284_CR16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/jm061152t","volume":"50","author":"M Bruncko","year":"2007","unstructured":"Bruncko M, Oost TK, Belli BA, Ding H, Joseph MK, Kunzer A, Martineau D, McClellan WJ, Mitten M, Ng SC et al (2007) Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL. J Med Chem 50(4):641\u2013662. doi: 10.1021\/jm061152t","journal-title":"J Med Chem"},{"issue":"14","key":"9284_CR17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1359-6446(05)03511-7","volume":"10","author":"RA Carr","year":"2005","unstructured":"Carr RA, Congreve M, Murray CW, Rees DC (2005) Fragment-based lead discovery: leads by design. Drug Discov Today 10(14):987\u2013992. doi: 10.1016\/S1359-6446(05)03511-7","journal-title":"Drug Discov Today"},{"issue":"1","key":"9284_CR18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1158\/1078-0432.CCR-07-1667","volume":"14","author":"S Chandarlapaty","year":"2008","unstructured":"Chandarlapaty S, Sawai A, Ye Q, Scott A, Silinski M, Huang K, Fadden P, Partdrige J, Hall S, Steed P et al (2008) SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers. Clin Cancer Res 14(1):240\u2013248. doi: 10.1158\/1078-0432.CCR-07-1667","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9284_CR19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1021\/jm060653b","volume":"50","author":"TA Chappie","year":"2007","unstructured":"Chappie TA, Humphrey JM, Allen MP, Estep KG, Fox CB, Lebel LA, Liras S, Marr ES, Menniti FS, Pandit J et al (2007) Discovery of a series of 6, 7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitors. J Med Chem 50(2):182\u2013185. doi: 10.1021\/jm060653b","journal-title":"J Med Chem"},{"issue":"6","key":"9284_CR20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.copbio.2007.09.003","volume":"18","author":"A Ciulli","year":"2007","unstructured":"Ciulli A, Abell C (2007) Fragment-based approaches to enzyme inhibition. Curr Opin Biotechnol 18(6):489\u2013496. doi: 10.1016\/j.copbio.2007.09.003","journal-title":"Curr Opin Biotechnol"},{"issue":"19","key":"9284_CR21","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S1359-6446(03)02831-9","volume":"8","author":"M Congreve","year":"2003","unstructured":"Congreve M, Carr R, Murray C, Jhoti H (2003) A \u2018rule of three\u2019 for fragment-based lead discovery? Drug Discov Today 8(19):876\u2013877. doi: 10.1016\/S1359-6446(03)02831-9","journal-title":"Drug Discov Today"},{"issue":"13","key":"9284_CR22","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1021\/jm8000373","volume":"51","author":"M Congreve","year":"2008","unstructured":"Congreve M, Chessari G, Tisi D, Woodhead AJ (2008) Recent developments in fragment-based drug discovery. J Med Chem 51(13):3661\u20133680. doi: 10.1021\/jm8000373","journal-title":"J Med Chem"},{"issue":"8","key":"9284_CR23","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/jm701314u","volume":"51","author":"TJ Crisman","year":"2008","unstructured":"Crisman TJ, Bender A, Milik M, Jenkins JL, Scheiber J, Sukuru SC, Fejzo J, Hommel U, Davies JW, Glick M (2008) \u201cVirtual fragment linking\u201d: an approach to identify potent binders from low affinity fragment hits. J Med Chem 51(8):2481\u20132491. doi: 10.1021\/jm701314u","journal-title":"J Med Chem"},{"issue":"10","key":"9284_CR24","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1021\/ci800229q","volume":"48","author":"TJ Crisman","year":"2008","unstructured":"Crisman TJ, Sisay MT, Bajorath J (2008) Ligand-target interaction-based weighting of substructures for virtual screening. J Chem Inf Model 48(10):1955\u20131964. doi: 10.1021\/ci800229q","journal-title":"J Chem Inf Model"},{"issue":"7","key":"9284_CR25","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1021\/jm061280h","volume":"50","author":"Y Dai","year":"2007","unstructured":"Dai Y, Hartandi K, Ji Z, Ahmed AA, Albert DH, Bauch JL, Bouska JJ, Bousquet PF, Cunha GA, Glaser KB et al (2007) Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N\u2032-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor. J Med Chem 50(7):1584\u20131597. doi: 10.1021\/jm061280h","journal-title":"J Med Chem"},{"issue":"2","key":"9284_CR26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pbiomolbio.2004.07.001","volume":"88","author":"K Das","year":"2005","unstructured":"Das K, Lewi PJ, Hughes SH, Arnold E (2005) Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors. Prog Biophys Mol Biol 88(2):209\u2013231. doi: 10.1016\/j.pbiomolbio.2004.07.001","journal-title":"Prog Biophys Mol Biol"},{"issue":"2","key":"9284_CR27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bmcl.2003.11.011","volume":"14","author":"B Dymock","year":"2004","unstructured":"Dymock B, Barril X, Beswick M, Collier A, Davies N, Drysdale M, Fink A, Fromont C, Hubbard RE, Massey A et al (2004) Adenine derived inhibitors of the molecular chaperone HSP90-SAR explained through multiple X-ray structures. Bioorg Med Chem Lett 14(2):325\u2013328. doi: 10.1016\/j.bmcl.2003.11.011","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"9284_CR28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/prot.340190305","volume":"19","author":"MB Eisen","year":"1994","unstructured":"Eisen MB, Wiley DC, Karplus M, Hubbard RE (1994) HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site. Proteins 19(3):199\u2013221. doi: 10.1002\/prot.340190305","journal-title":"Proteins"},{"issue":"6","key":"9284_CR29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.copbio.2006.10.007","volume":"17","author":"DA Erlanson","year":"2006","unstructured":"Erlanson DA (2006) Fragment-based lead discovery: a chemical update. Curr Opin Biotechnol 17(6):643\u2013652. doi: 10.1016\/j.copbio.2006.10.007","journal-title":"Curr Opin Biotechnol"},{"issue":"10","key":"9284_CR30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1074-5521(00)80022-8","volume":"6","author":"J Fejzo","year":"1999","unstructured":"Fejzo J, Lepre CA, Peng JW, Bemis GW, Ajay MurckoMA, Moore JM (1999) The SHAPES strategy: an NMR-based approach for lead generation in drug discovery. Chem Biol 6(10):755\u2013769. doi: 10.1016\/S1074-5521(00)80022-8","journal-title":"Chem Biol"},{"issue":"10","key":"9284_CR31","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/anie.200462457","volume":"44","author":"T Fink","year":"2005","unstructured":"Fink T, Bruggesser H, Reymond JL (2005) Virtual exploration of the small-molecule chemical universe below 160 Daltons. Angew Chem Int Ed Engl 44(10):1504\u20131508. doi: 10.1002\/anie.200462457","journal-title":"Angew Chem Int Ed Engl"},{"issue":"29","key":"9284_CR32","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.2174\/092986706779026165","volume":"13","author":"N Foloppe","year":"2006","unstructured":"Foloppe N, Hubbard R (2006) Towards predictive ligand design with free-energy based computational methods? Curr Med Chem 13(29):3583\u20133608. doi: 10.2174\/092986706779026165","journal-title":"Curr Med Chem"},{"key":"9284_CR33","unstructured":"Froning KJ, Felce JD, Jessen KA, Leonard S, Gutierrez A, Tang C, Huser N, Do T, Gessert S, Aubol B et al. (2007) SGX523: a potent and highly selective small molecule inhibitor of the MET receptor tyrosine kinase. http:\/\/www.sgxpharma.com\/pipeline\/documents\/SGX523METAACR07.pdf"},{"issue":"24","key":"9284_CR34","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1021\/jm070825k","volume":"50","author":"S Geschwindner","year":"2007","unstructured":"Geschwindner S, Olsson LL, Albert JS, Deinum J, Edwards PD, de Beer T, Folmer RH (2007) Discovery of a novel warhead against beta-secretase through fragment-based lead generation. J Med Chem 50(24):5903\u20135911. doi: 10.1021\/jm070825k","journal-title":"J Med Chem"},{"key":"9284_CR35","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1021\/jm049131r","volume":"48","author":"PJ Hajduk","year":"2005","unstructured":"Hajduk PJ (2005) Druggability indices for protein targets derived from NMR-based screening data. J Med Chem 48:2518\u20132525. doi: 10.1021\/jm049131r","journal-title":"J Med Chem"},{"issue":"24","key":"9284_CR36","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1021\/jm060511h","volume":"49","author":"PJ Hajduk","year":"2006","unstructured":"Hajduk PJ (2006) Fragment-based drug design: how big is too big? J Med Chem 49(24):6972\u20136976. doi: 10.1021\/jm060511h","journal-title":"J Med Chem"},{"issue":"3","key":"9284_CR37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrd2220","volume":"6","author":"PJ Hajduk","year":"2007","unstructured":"Hajduk PJ, Greer J (2007) A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev Drug Discov 6(3):211\u2013219. doi: 10.1038\/nrd2220","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"9284_CR38","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/ci000403i","volume":"41","author":"MM Hann","year":"2001","unstructured":"Hann MM, Leach AR, Harper G (2001) Molecular complexity and its impact on the probability of finding leads for drug discovery. J Chem Inf Comput Sci 41(3):856\u2013864. doi: 10.1021\/ci000403i","journal-title":"J Chem Inf Comput Sci"},{"issue":"2","key":"9284_CR39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/jm0495778","volume":"48","author":"MJ Hartshorn","year":"2005","unstructured":"Hartshorn MJ, Murray CW, Cleasby A, Frederickson M, Tickle IJ, Jhoti H (2005) Fragment-based lead discovery using X-ray crystallography. J Med Chem 48(2):403\u2013413. doi: 10.1021\/jm0495778","journal-title":"J Med Chem"},{"issue":"1","key":"9284_CR40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/jm0603365","volume":"50","author":"PC Hawkins","year":"2007","unstructured":"Hawkins PC, Skillman AG, Nicholls A (2007) Comparison of shape-matching and docking as virtual screening tools. J Med Chem 50(1):74\u201382. doi: 10.1021\/jm0603365","journal-title":"J Med Chem"},{"issue":"1","key":"9284_CR41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng1692","volume":"38","author":"A Helgadottir","year":"2006","unstructured":"Helgadottir A, Manolescu A, Helgason A, Thorleifsson G, Thorsteinsdottir U, Gudbjartsson DF, Gretarsdottir S, Magnusson KP, Gudmundsson G, Hicks A et al (2006) A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 38(1):68\u201374. doi: 10.1038\/ng1692","journal-title":"Nat Genet"},{"issue":"3","key":"9284_CR42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cbpa.2008.02.005","volume":"12","author":"T Hesterkamp","year":"2008","unstructured":"Hesterkamp T, Whittaker M (2008) Fragment-based activity space: smaller is better. Curr Opin Chem Biol 12(3):260\u2013268. doi: 10.1016\/j.cbpa.2008.02.005","journal-title":"Curr Opin Chem Biol"},{"issue":"16","key":"9284_CR43","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.2174\/156802607782341064","volume":"7","author":"T Hesterkamp","year":"2007","unstructured":"Hesterkamp T, Barker J, Davenport A, Whittaker M (2007) Fragment based drug discovery using fluorescence correlation: spectroscopy techniques: challenges and solutions. Curr Top Med Chem 7(16):1582\u20131591. doi: 10.2174\/156802607782341064","journal-title":"Curr Top Med Chem"},{"issue":"7","key":"9284_CR44","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrd2083","volume":"5","author":"SA Hofstadler","year":"2006","unstructured":"Hofstadler SA, Sannes-Lowery KA (2006) Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes. Nat Rev Drug Discov 5(7):585\u2013595. doi: 10.1038\/nrd2083","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"9284_CR45","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","volume":"9","author":"AL Hopkins","year":"2004","unstructured":"Hopkins AL, Groom CR, Alex A (2004) Ligand efficiency: a useful metric for lead selection. Drug Discov Today 9(10):430\u2013431. doi: 10.1016\/S1359-6446(04)03069-7","journal-title":"Drug Discov Today"},{"issue":"2","key":"9284_CR46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1021\/jm800984v","volume":"52","author":"S Howard","year":"2009","unstructured":"Howard S, Berdini V, Boulstridge JA, Carr MG, Cross DM, Curry J, Devine LA, Early TR, Fazal L, Gill AL et al (2009) Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity. J Med Chem 52(2):379\u2013388. doi: 10.1021\/jm800984v","journal-title":"J Med Chem"},{"issue":"23","key":"9284_CR47","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1021\/jm049726m","volume":"47","author":"D Huang","year":"2004","unstructured":"Huang D, Caflisch A (2004) Efficient evaluation of binding free energy using continuum electrostatics solvation. J Med Chem 47(23):5791\u20135797. doi: 10.1021\/jm049726m","journal-title":"J Med Chem"},{"issue":"3","key":"9284_CR48","first-page":"289","volume":"10","author":"RE Hubbard","year":"2007","unstructured":"Hubbard RE, Chen I, Davis B (2007) Informatics and modeling challenges in fragment-based drug discovery. Curr Opin Drug Discov Devel 10(3):289\u2013297","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"16","key":"9284_CR49","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.2174\/156802607782341109","volume":"7","author":"RE Hubbard","year":"2007","unstructured":"Hubbard RE, Davis B, Chen I, Drysdale MJ (2007) The SeeDs approach: integrating fragments into drug discovery. Curr Top Med Chem 7(16):1568\u20131581. doi: 10.2174\/156802607782341109","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"9284_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1747-0285.2007.00535.x","volume":"70","author":"JR Huth","year":"2007","unstructured":"Huth JR, Park C, Petros AM, Kunzer AR, Wendt MD, Wang X, Lynch CL, Mack JC, Swift KM, Judge RA et al (2007) Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies. Chem Biol Drug Des 70(1):1\u201312. doi: 10.1111\/j.1747-0285.2007.00535.x","journal-title":"Chem Biol Drug Des"},{"key":"9284_CR51","volume-title":"Fragment-based approaches to lead discovery","author":"W Jahnke","year":"2007","unstructured":"Jahnke W, Erlanson DA (2007) Fragment-based approaches to lead discovery. Wiley, Weinheim"},{"issue":"6","key":"9284_CR52","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1021\/jm040840e","volume":"48","author":"PA Janssen","year":"2005","unstructured":"Janssen PA, Lewi PJ, Arnold E, Daeyaert F, de Jonge M, Heeres J, Koymans L, Vinkers M, Guillemont J, Pasquier E et al (2005) In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2, 6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (R278474, rilpivirine). J Med Chem 48(6):1901\u20131909. doi: 10.1021\/jm040840e","journal-title":"J Med Chem"},{"key":"9284_CR53","first-page":"169","volume":"3","author":"H Jhoti","year":"2007","unstructured":"Jhoti H (2007) Fragment-based drug discovery using rational design. Ernst Schering Found Symp Proc 3:169\u2013185","journal-title":"Ernst Schering Found Symp Proc"},{"key":"9284_CR54","doi-asserted-by":"crossref","DOI":"10.1007\/1-4020-4407-0","volume-title":"Structure-based drug discovery","author":"H Jhoti","year":"2007","unstructured":"Jhoti H, Leach AR (2007) Structure-based drug discovery. Springer, Dordrecht"},{"issue":"5","key":"9284_CR55","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cbpa.2007.07.010","volume":"11","author":"H Jhoti","year":"2007","unstructured":"Jhoti H, Cleasby A, Verdonk M, Williams G (2007) Fragment-based screening using X-ray crystallography and NMR spectroscopy. Curr Opin Chem Biol 11(5):485\u2013493. doi: 10.1016\/j.cbpa.2007.07.010","journal-title":"Curr Opin Chem Biol"},{"issue":"6956","key":"9284_CR56","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature01913","volume":"425","author":"A Kamal","year":"2003","unstructured":"Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, Burrows FJ (2003) A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425(6956):407\u2013410. doi: 10.1038\/nature01913","journal-title":"Nature"},{"issue":"18","key":"9284_CR57","doi-asserted-by":"crossref","first-page":"9997","DOI":"10.1073\/pnas.96.18.9997","volume":"96","author":"ID Kuntz","year":"1999","unstructured":"Kuntz ID, Chen K, Sharp KA, Kollman PA (1999) The maximal affinity of ligands. Proc Natl Acad Sci USA 96(18):9997\u201310002. doi: 10.1073\/pnas.96.18.9997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"9284_CR58","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1039\/b610069b","volume":"2","author":"AR Leach","year":"2006","unstructured":"Leach AR, Hann MM, Burrows JN, Griffen EJ (2006) Fragment screening: an introduction. Mol Biosyst 2(9):430\u2013446. doi: 10.1039\/b610069b","journal-title":"Mol Biosyst"},{"issue":"11","key":"9284_CR59","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","volume":"6","author":"PD Leeson","year":"2007","unstructured":"Leeson PD, Springthorpe B (2007) The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 6(11):881\u2013890. doi: 10.1038\/nrd2445","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"9284_CR60","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1517\/17460441.2.12.1555","volume":"2","author":"C Lepre","year":"2007","unstructured":"Lepre C (2007) Fragment-based drug discovery using the SHAPES method. Expert Opin Drug Discov 2(12):1555\u20131566. doi: 10.1517\/17460441.2.12.1555","journal-title":"Expert Opin Drug Discov"},{"issue":"3","key":"9284_CR61","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/ci970429i","volume":"38","author":"XQ Lewell","year":"1998","unstructured":"Lewell XQ, Judd DB, Watson SP, Hann MM (1998) RECAP\u2013retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J Chem Inf Comput Sci 38(3):511\u2013522. doi: 10.1021\/ci970429i","journal-title":"J Chem Inf Comput Sci"},{"key":"9284_CR62","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1021\/jm800515r","volume":"51","author":"E Loukine","year":"2008","unstructured":"Loukine E, Auer J, Bajorath J (2008) Formal concept analysis for the identification of molecular fragment combinations specific for active and highly potent compounds. J Med Chem 51:5342\u20135348. doi: 10.1021\/jm800515r","journal-title":"J Med Chem"},{"issue":"14","key":"9284_CR63","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1021\/jm0700316","volume":"50","author":"GM Makara","year":"2007","unstructured":"Makara GM (2007) On sampling of fragment space. J Med Chem 50(14):3214\u20133221. doi: 10.1021\/jm0700316","journal-title":"J Med Chem"},{"issue":"26","key":"9284_CR64","doi-asserted-by":"crossref","first-page":"20052","DOI":"10.1074\/jbc.M001713200","volume":"275","author":"N Mashhoon","year":"2000","unstructured":"Mashhoon N, DeMaggio AJ, Tereshko V, Bergmeier SC, Egli M, Hoekstra MF, Kuret J (2000) Crystal structure of a conformation-selective casein kinase-1 inhibitor. J Biol Chem 275(26):20052\u201320060. doi: 10.1074\/jbc.M001713200","journal-title":"J Biol Chem"},{"issue":"3","key":"9284_CR65","first-page":"355","volume":"8","author":"WR Moore Jr","year":"2005","unstructured":"Moore WR Jr (2005) Maximizing discovery efficiency with a computationally driven fragment approach. Curr Opin Drug Discov Devel 8(3):355\u2013364","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"6","key":"9284_CR66","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/jm0611962","volume":"50","author":"CW Murray","year":"2007","unstructured":"Murray CW, Callaghan O, Chessari G, Cleasby A, Congreve M, Frederickson M, Hartshorn MJ, McMenamin R, Patel S, Wallis N (2007) Application of fragment screening by X-ray crystallography to beta-secretase. J Med Chem 50(6):1116\u20131123. doi: 10.1021\/jm0611962","journal-title":"J Med Chem"},{"issue":"16","key":"9284_CR67","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.2174\/156802607782341073","volume":"7","author":"T Neumann","year":"2007","unstructured":"Neumann T, Junker HD, Schmidt K, Sekul R (2007) SPR-based fragment screening: advantages and applications. Curr Top Med Chem 7(16):1630\u20131642. doi: 10.2174\/156802607782341073","journal-title":"Curr Top Med Chem"},{"issue":"14","key":"9284_CR68","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1073\/pnas.0800587105","volume":"105","author":"T O\u2019Hare","year":"2008","unstructured":"O\u2019Hare T, Eide CA, Tyner JW, Corbin AS, Wong MJ, Buchanan S, Holme K, Jessen KA, Tang C, Lewis HA et al (2008) SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinib. Proc Natl Acad Sci USA 105(14):5507\u20135512. doi: 10.1073\/pnas.0800587105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"9284_CR69","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1016\/j.bmcl.2008.07.073","volume":"18","author":"JD Oslob","year":"2008","unstructured":"Oslob JD, Romanowski MJ, Allen DA, Baskaran S, Bui M, Elling RA, Flanagan WM, Fung AD, Hanan EJ, Harris S et al (2008) Discovery of a potent and selective aurora kinase inhibitor. Bioorg Med Chem Lett 18(17):4880\u20134884. doi: 10.1016\/j.bmcl.2008.07.073","journal-title":"Bioorg Med Chem Lett"},{"issue":"21","key":"9284_CR70","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.1021\/jm800669s","volume":"51","author":"CM Park","year":"2008","unstructured":"Park CM, Bruncko M, Adickes J, Bauch J, Ding H, Kunzer A, Marsh KC, Nimmer P, Shoemaker AR, Song X et al (2008) Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins. J Med Chem 51(21):6902\u20136915. doi: 10.1021\/jm800669s","journal-title":"J Med Chem"},{"issue":"8","key":"9284_CR71","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1021\/jm701255b","volume":"51","author":"CH Reynolds","year":"2008","unstructured":"Reynolds CH, Tounge BA, Bembenek SD (2008) Ligand binding efficiency: trends, physical basis, and implications. J Med Chem 51(8):2432\u20132438. doi: 10.1021\/jm701255b","journal-title":"J Med Chem"},{"issue":"5","key":"9284_CR72","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1021\/jm040163o","volume":"48","author":"TS Rush 3rd","year":"2005","unstructured":"Rush TS 3rd, Grant JA, Mosyak L, Nicholls A (2005) A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. J Med Chem 48(5):1489\u20131495. doi: 10.1021\/jm040163o","journal-title":"J Med Chem"},{"issue":"5","key":"9284_CR73","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1158\/1541-7786.MCR-07-2001","volume":"6","author":"E Sala","year":"2008","unstructured":"Sala E, Mologni L, Truffa S, Gaetano C, Bollag GE, Gambacorti-Passerini C (2008) BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells. Mol Cancer Res 6(5):751\u2013759. doi: 10.1158\/1541-7786.MCR-07-2001","journal-title":"Mol Cancer Res"},{"issue":"23","key":"9284_CR74","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.2174\/0929867023368755","volume":"9","author":"G Schneider","year":"2002","unstructured":"Schneider G (2002) Trends in virtual combinatorial library design. Curr Med Chem 9(23):2095\u20132101","journal-title":"Curr Med Chem"},{"issue":"8","key":"9284_CR75","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrd1799","volume":"4","author":"G Schneider","year":"2005","unstructured":"Schneider G, Fechner U (2005) Computer-based de novo design of drug-like molecules. Nat Rev Drug Discov 4(8):649\u2013663. doi: 10.1038\/nrd1799","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"9284_CR76","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2174\/1568026054637700","volume":"5","author":"A Schuffenhauer","year":"2005","unstructured":"Schuffenhauer A, Ruedisser S, Marzinzik AL, Jahnke W, Blommers M, Selzer P, Jacoby E (2005) Library design for fragment based screening. Curr Top Med Chem 5(8):751\u2013762. doi: 10.2174\/1568026054637700","journal-title":"Curr Top Med Chem"},{"issue":"23\u201324","key":"9284_CR77","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.drudis.2007.08.005","volume":"12","author":"G Siegal","year":"2007","unstructured":"Siegal G, Ab E, Schultz J (2007) Integration of fragment screening and library design. Drug Discov Today 12(23\u201324):1032\u20131039. doi: 10.1016\/j.drudis.2007.08.005","journal-title":"Drug Discov Today"},{"issue":"1\u20132","key":"9284_CR78","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drudis.2006.11.011","volume":"12","author":"MG Siegel","year":"2007","unstructured":"Siegel MG, Vieth M (2007) Drugs in other drugs: a new look at drugs as fragments. Drug Discov Today 12(1\u20132):71\u201379. doi: 10.1016\/j.drudis.2006.11.011","journal-title":"Drug Discov Today"},{"issue":"6","key":"9284_CR79","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1093-3263(98)00008-4","volume":"15","author":"M Snarey","year":"1997","unstructured":"Snarey M, Terrett NK, Willett P, Wilton DJ (1997) Comparison of algorithms for dissimilarity-based compound selection. J Mol Graph Model 15(6):372\u2013385. doi: 10.1016\/S1093-3263(98)00008-4","journal-title":"J Mol Graph Model"},{"issue":"10","key":"9284_CR80","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1021\/ci800135h","volume":"48","author":"VJ Sykora","year":"2008","unstructured":"Sykora VJ, Leahy DE (2008) Chemical descriptors library (CDL): a generic, open source software library for chemical informatics. J Chem Inf Model 48(10):1931\u20131942. doi: 10.1021\/ci800135h","journal-title":"J Chem Inf Model"},{"key":"9284_CR81","doi-asserted-by":"crossref","unstructured":"Taldone T, Sun W, Chiosis G (2008) Discovery and development of heat shock protein 90 inhibitors. Bioorg Med Chem","DOI":"10.1016\/j.bmc.2008.10.087"},{"issue":"4","key":"9284_CR82","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/prot.21369","volume":"67","author":"JD Taylor","year":"2007","unstructured":"Taylor JD, Gilbert PJ, Williams MA, Pitt WR, Ladbury JE (2007) Identification of novel fragment compounds targeted against the pY pocket of v-Src SH2 by computational and NMR screening and thermodynamic evaluation. Proteins 67(4):981\u2013990. doi: 10.1002\/prot.21369","journal-title":"Proteins"},{"issue":"2","key":"9284_CR83","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00129424","volume":"6","author":"CL Verlinde","year":"1992","unstructured":"Verlinde CL, Rudenko G, Hol WG (1992) In search of new lead compounds for trypanosomiasis drug design: a protein structure-based linked-fragment approach. J Comput Aided Mol Des 6(2):131\u2013147. doi: 10.1007\/BF00129424","journal-title":"J Comput Aided Mol Des"},{"issue":"15","key":"9284_CR84","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2174\/156802607782194725","volume":"7","author":"HO Villar","year":"2007","unstructured":"Villar HO, Hansen MR (2007) Computational techniques in fragment based drug discovery. Curr Top Med Chem 7(15):1509\u20131513. doi: 10.2174\/156802607782194725","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"9284_CR85","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1021\/jm0103920","volume":"45","author":"CK Wada","year":"2002","unstructured":"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH et al (2002) Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors. J Med Chem 45(1):219\u2013232. doi: 10.1021\/jm0103920","journal-title":"J Med Chem"},{"issue":"14","key":"9284_CR86","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1073\/pnas.0700279104","volume":"104","author":"H Wang","year":"2007","unstructured":"Wang H, Liu Y, Hou J, Zheng M, Robinson H, Ke H (2007) Structural insight into substrate specificity of phosphodiesterase 10. Proc Natl Acad Sci USA 104(14):5782\u20135787. doi: 10.1073\/pnas.0700279104","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"9284_CR87","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","volume":"49","author":"GL Warren","year":"2006","unstructured":"Warren GL, Andrews CW, Capelli AM, Clarke B, LaLonde J, Lambert MH, Lindvall M, Nevins N, Semus SF, Senger S et al (2006) A critical assessment of docking programs and scoring functions. J Med Chem 49(20):5912\u20135931. doi: 10.1021\/jm050362n","journal-title":"J Med Chem"},{"issue":"16","key":"9284_CR88","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1021\/jm800382h","volume":"51","author":"PG Wyatt","year":"2008","unstructured":"Wyatt PG, Woodhead AJ, Berdini V, Boulstridge JA, Carr MG, Cross DM, Davis DJ, Devine LA, Early TR, Feltell RE et al (2008) Identification of N-(4-piperidinyl)-4-(2, 6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design. J Med Chem 51(16):4986\u20134999. doi: 10.1021\/jm800382h","journal-title":"J Med Chem"},{"issue":"6","key":"9284_CR89","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1158\/1078-0432.CCR-06-2966","volume":"13","author":"W Xu","year":"2007","unstructured":"Xu W, Neckers L (2007) Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells. Clin Cancer Res 13(6):1625\u20131629. doi: 10.1158\/1078-0432.CCR-06-2966","journal-title":"Clin Cancer Res"},{"issue":"16","key":"9284_CR90","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2174\/156802607782341055","volume":"7","author":"ER Zartler","year":"2007","unstructured":"Zartler ER, Mo H (2007) Practical aspects of NMR-based fragment discovery. Curr Top Med Chem 7(16):1592\u20131599. doi: 10.2174\/156802607782341055","journal-title":"Curr Top Med Chem"},{"key":"9284_CR91","doi-asserted-by":"crossref","DOI":"10.1002\/9780470721551","volume-title":"Fragment-based drug discovery: a practical approach","author":"ER Zartler","year":"2008","unstructured":"Zartler ER, Shapiro MJ (2008) Fragment-based drug discovery: a practical approach. Wiley, Chichester"},{"issue":"3","key":"9284_CR92","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cbpa.2008.02.007","volume":"12","author":"JZ Zhou","year":"2008","unstructured":"Zhou JZ (2008) Structure-directed combinatorial library design. Curr Opin Chem Biol 12(3):379\u2013385. doi: 10.1016\/j.cbpa.2008.02.007","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"9284_CR93","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/CCO.0b013e3282f310f6","volume":"20","author":"DS Ziegler","year":"2008","unstructured":"Ziegler DS, Kung AL (2008) Therapeutic targeting of apoptosis pathways in cancer. Curr Opin Oncol 20(1):97\u2013103. doi: 10.1097\/CCO.0b013e3282f310f6","journal-title":"Curr Opin Oncol"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-009-9284-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-009-9284-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-009-9284-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T17:55:24Z","timestamp":1685037324000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-009-9284-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,17]]},"references-count":93,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["9284"],"URL":"https:\/\/doi.org\/10.1007\/s10822-009-9284-1","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,17]]}}}